By increasing and prolonging active incretin levels, JANUVIA increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner
Research shows metabolic benefits can be sustained over two years with continuous, long-term use, especially combined with ongoing support and hormone optimization
Get a Quote Dulaglutide 3mg GLP-1 receptor agonist consisting of two GLP-1 analog peptides covalently linked to a modified human IgG4 Fc fragment
Cationic, amphiphilic peptides that tend to welt reconstitute better in BAC water with 0.9% NaCl: SS-31, MOTS-c, the GH secretagogues (sermorelin, ipamorelin, tesamorelin, CJC-1295), and VIP and kisspeptin-10
For me, this highlights an important point: pharmaceutical innovation does not end with the development of an effective medicine
Terrill PI, Edwards BA, Nemati S, et al